October 25, 2022

Supplementation with omega-3 or vitamin D may be useful for preventing and treating pain in patients with SCD. One study assessed the effects of supplementation in conjunction with standard therapy. A common clinical feature present in sickle cell disease (SCD) is pain caused by the distortion of red blood cells and the subsequent blocking of...

Research suggests that minorities are less likely to be prescribed newer diabetes medications than their White counterparts of similar socioeconomic status and diabetes management. As of 2021, the United States Food and Drug Administration (FDA) approved nearly 60 drugs for treating Type 2 Diabetes, and almost 100 additional antidiabetic agents were evaluated in clinical trials1....

Minority underrepresentation in clinical trials can adversely affect patient outcomes in minority populations and further increase racial disparities. Racial disparities in clinical trials adversely affect patient outcomes in minority populations. Although historically, Black populations have been used as unconsenting research participants in studies such as the Tuskegee Syphilis Experiment which began in 1932, or the...

Research shows that Asian, Hispanic, and Black Americans are at increased risk for diabetes at lower weights and younger ages than White Americans. Adult-onset diabetes is one of the most common chronic conditions in adults in the United States. According to the Centers for Disease Control’s (CDC) 2021 statistics, 11.3% of the U.S. population has...

JiaDe (Jeff) Yu, MD, specializes in allergic contact dermatitis and occupational dermatitis in both adults and children. He is a board-certified dermatologist with further training in pediatric dermatology. Eczema, complicated inherited genetic skin disorders (genodermatoses), and the complete range of pediatric dermatology. In this interview, Dr. JiaDe (Jeff) Yu sheds more light on eczema, also...

Children and youth with sickle cell disease (SCD) can benefit from digital interventions for self management of their disease. One study assessed the engagement and usefulness of a digital intervention in youth with SCD. Sickle cell disease (SCD) is marked by episodes of sudden, severe pain and increased risk for chronic pain. A digital platform...

Typically, monthly blood transfusion therapy is an option for children with sickle cell anemia (SCA) followed by hydroxyurea therapy. As blood transfusion therapy is not feasible in Africa, different strategies were investigated for stroke prevention in SCA. Stroke risk in children with sickle cell anemia (SCA) is 100 times times that for children without SCA,...

In this interview, we speak with Dr. Kaminska about Olumiant about a novel treatment for alopecia. In addition to explaining what it is and why it can be a good option for certain patients, Dr. Kaminska provides a fair assessment of its effectiveness and safety. MDNewsline: What is the efficacy and safety of Olumiant in...